MedTrace Logo

Muscle Ultrasound for Sarcopenia Leading to Early Detection

NCT02319850 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34

Last updated 2018-03-01

No results posted yet for this study

Summary

Sarcopenia is an age-related loss of muscle mass that may affect over 25% of individuals over the age of 60 and results in a 3 to 4 times increased likelihood of developing a disability. Despite these observations, sarcopenia is rarely subject to a systematic screening process as a part of customary geriatric care. Furthermore, when lean body mass (LBM) is measured via dual energy X-ray absorptiometry (DXA) in older adults, it is typically within a reactive, hospital-based, model of healthcare where muscle wasting is only assessed after a loss of functional independence. The investigators propose an affordable, portable screening method with ultrasound imaging to be performed in primary care settings.

The investigators long term goal is to identify individuals at risk, and intervene with treatments that may prevent the onset of debilitating loss of muscle function in the elderly.

Conditions

Interventions

RADIATION

DXA scanning

Exposure: Participants will undergo DXA scanning in the supine position per manufacturer guidelines to estimate absolute and percentage of total lean body mass (LBM) and body fat (BF).

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • Children's National Research Institute

    collaborator OTHER

  • George Washington University

    lead OTHER

Principal Investigators

  • Loretta DiPietro, PhD, MPH · George Washington University

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02319850 on ClinicalTrials.gov